相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Imaging of Neuroendocrine Differentiation of Prostate Cancer: A Case Series
Amir Iravani et al.
CLINICAL GENITOURINARY CANCER (2021)
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)
Fred Saad et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2021)
Prostate Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines
Edward Schaeffer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S. Hofman et al.
LANCET (2021)
Automated radiosynthesis of 68Ga for large-scale routine production using 68Zn pressed target
Aiman H. Alnahwi et al.
APPLIED RADIATION AND ISOTOPES (2020)
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2019)
Neuroendocrine differentiation in castration resistant prostate cancer. Nuclear medicine radiopharmaceuticals and imaging techniques: A narrative review
Sharjeel Usmani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
Majid Assadi et al.
CLINICAL NUCLEAR MEDICINE (2019)
Treatment-emergent neuroendocrine prostate cancer: molecularly driven clinical guidelines
Pier-Luc Clermont et al.
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY (2019)
Clinical and molecular features of treatment-related neuroendocrine prostate cancer
Shusuke Akamatsu et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair H. Davies et al.
NATURE REVIEWS UROLOGY (2018)
The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival
Vincent Q. Trinh et al.
PROSTATE (2018)
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL
A. H. Bryce et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Emerging Variants of Castration-Resistant Prostate Cancer
Panagiotis J. Vlachostergios et al.
CURRENT ONCOLOGY REPORTS (2017)
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy
Fannie Morin et al.
EUROPEAN UROLOGY FOCUS (2017)
PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine Differentiation in Patients With Castrate-Resistant Prostate Cancer
Ofer Nathan Gofrit et al.
CLINICAL NUCLEAR MEDICINE (2017)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort
Dominique Trudel et al.
EUROPEAN JOURNAL OF CANCER (2014)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Role of Ga-68-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on In-111-DTPA-Octreotide Scintigraphy
Rajaventhan Srirajaskanthan et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Photovoice: A Review of the Literature in Health and Public Health
Caricia Catalani et al.
HEALTH EDUCATION & BEHAVIOR (2010)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
